Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
By: GlobeNewswire - 04 Mar 2024Back to overview list

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions by managerial staff:

The Board of Directors has previously granted share options and performance shares in ALK-Abelló A/S, re. company release no. 10/2021 of 26 March 2021. The right to share options and performance shares may be achieved in March 2024, provided that ALK achieves the pre-agreed targets for vesting and that the employment relationship with the ALK Group has not been terminated by the Company on objective grounds or terminated.

The final calculations have now been completed, and final allocation of share options and delivery of performance shares have taken place as stated in the attached pdf-file.

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Maiken Riise Andersen, tel. +45 5054 1434

Attachment


Copyright 2024 GlobeNewswire Back to overview list
to the top ↑